Clinical evolution of the functional capability in patients with systemic sclerosis treated with cyclophosphamide and reduce dose of steroids

Authors

  • Susel Elisabet Remedios Batista
  • Karel Duran Marrero
  • Alfredo Hernández Martínez
  • Salem Grace Ramírez
  • Eduardo Fermín Hernández

Abstract

Introduction. The systemic sclerosis is an autoimmune disease of the connective tissue where the vasculopathy happens initially and persist during all the disease. The functional capability (FC), the commitment of the system reveals muscleskeletic of the patient, than little lime or incapacities of temporary form or permanent the realization of certain shows, measurable with the instrument of evaluation. Methods. The questionnaire that was utilized is the Cochin Hand Function scale (CHFS), measure the degree of disability of the hands. The patients split into two groups according to the clinical stages obtained in previous published study. In the group A (clinical stages I and II) they included 16 patients and 15 patients (clinical stages III and IV) included B themselves in the group, (annex 2). Results. The applied medical treatment, previous validation, you improved the functional capability of the patients of both groups A and B, that is in clinical premature and overdue stages. Conclusions. Significant improvement in the functional capability of patients affected of systemic sclerosis, with the medical treatment applied, with clinical stability and humoral from initial stages of the disease was caught up with.

Downloads

Published

2021-10-30

How to Cite

1.
Remedios Batista SE, Duran Marrero K, Hernández Martínez A, Grace Ramírez S, Fermín Hernández E. Clinical evolution of the functional capability in patients with systemic sclerosis treated with cyclophosphamide and reduce dose of steroids. Invest Medicoquir [Internet]. 2021 Oct. 30 [cited 2025 Dec. 20];14(1). Available from: https://revcimeq.sld.cu/index.php/imq/article/view/762

Issue

Vol. 14 No. 1 (2022): Enero-Junio

Section

Research article

License

The authors retain copyright and all unrestricted publication rights.

Medicoquirúrgicas Research is licensed under the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0) and follows the SciELO Publishing Schema (SciELO PS) for publishing in XML format.

You are free to:

  • Share — copy and redistribute the material in any medium or format.
  • Adapt — remix, transform, and build upon the material.

The license cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do this in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Non-Commercial — You may not use the material for commercial purposes.
No Additional Restrictions — You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where their use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all the permissions you need for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.